3 terminated, 3 unknown, 2 completed. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Terminated 3, Unknown 3, Completed 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Lung Disease: new trials by email Literature Review of Lung Disease trials Research Report on Lung Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nondependent Lung Ventilation and Fluid Responsiveness High Frequency Positive Pressure Ventilation, Continuous Positive Airway Pressure - Lung Disease, Undergoing Thoracosocpic Surgery | Phase 3 | Unknown | Imam Abdulrahman Bin Faisal University | 62 | 2019-01-01 | 2018-05-24 |
| The Effectiveness of BreatheMAX Breathing Device on Secretion Clearance BreatheMAX breathing device - Lung Disease | Phase 2 / Phase 3 | Unknown | Khon Kaen University | 14 | 2009-08-01 | 2010-03-23 |
| Using Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in Neonates Furosemide, Saline - Lung Disease | Phase 3 | Unknown | The Hospital for Sick Children | 64 | 2007-01-01 | 2008-02-20 |
| Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies Nitric oxide, Placebo - Lung Disease | Phase 3 | Completed | Mallinckrodt | 800 | 2005-05-29 | 2021-02-05 |
| The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) Interferon gamma-1b ("Actimmune") - Idiopathic Pulmonary Fibrosis, Lung Disease | Phase 3 | Terminated | InterMune | 826 | 2003-12-01 | 2009-07-02 |
| An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF Interferon gamma-1b - Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis | Phase 3 | Terminated | InterMune | 91 | 2003-11-01 | 2007-11-06 |
| Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study Imatinib Mesylate (Gleevec) - Idiopathic Pulmonary Fibrosis, Lung Disease | Phase 2 / Phase 3 | Completed | Daniels, Craig E., M.D. | 120 | 2003-04-01 | 2005-10-05 |
| A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone interferon-gamma 1b, azathioprine - Lung Disease, Pulmonary Fibrosis | Phase 3 | Terminated | InterMune | 2002-04-01 | 2007-11-06 |
Lung Diseases (8) · Idiopathic Pulmonary Fibrosis (4) · Pulmonary Fibrosis (4) · Fibrosis (2) · Edema (1) · Lung Diseases, Interstitial (1) · Respiratory Tract Diseases (1)
Respiratory Tract Diseases (7) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Lung Diseases, Interstitial (3) · Fibrosis (2) · Signs and Symptoms (1)
interferon gamma-1b (2) · Azathioprine (1) · Continuous Positive Airway Pressure (1) · Furosemide (1) · High-Frequency Ventilation (1) · Imatinib Mesylate (1) · Interferon-gamma (1) · Nitric Oxide (1) · Sodium Chloride (1)
InterMune (3) · Daniels, Craig E., M.D. (1) · Imam Abdulrahman Bin Faisal University (1) · Khon Kaen University (1) · Mallinckrodt (1) · The Hospital for Sick Children (1)
Italy (2) · United States (2) · Belgium (1) · Canada (1) · Finland (1) · France (1) · Germany (1) · Netherlands (1) · Saudi Arabia (1) · Spain (1) · Sweden (1) · Thailand (1) · United Kingdom (1)
Abdulmohsen A Al Ghamdi, MD (1) · Chulee CU Jones, Philosophy (1) · Craig E Daniels, MD (1) · Joseph Lasky, MD (1) · Mohamed R El Tahan, MD (1) · Patrick McNamara, MD (1) · Steven Porter, MD (1) · Sujittra Kluayhomthong, Bachelor (1) · Wilaiwan Khrisanapant, Philosophy (1)
PMID 19570573, PMID 20007927, PMID 20655106, PMID 23940237, PMID 24311766, PMID 28046032, PMID 28657784, PMID 31047956, PMID 33434107, PMID 35688625, PMID 38238788
2004 (1)